Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Fractyl Health (GUTS) EBITDA Margin (2023 - 2024)

Historic EBITDA Margin for Fractyl Health (GUTS) over the last 2 years, with Q4 2024 value amounting to 840333.33%.

  • Fractyl Health's EBITDA Margin fell 6548904800.0% to 840333.33% in Q4 2024 from the same period last year, while for Dec 2024 it was 100570.97%, marking a year-over-year decrease of 582076300.0%. This contributed to the annual value of 100570.97% for FY2024, which is 582076300.0% down from last year.
  • Fractyl Health's EBITDA Margin amounted to 840333.33% in Q4 2024, which was down 6548904800.0% from 169957.14% recorded in Q3 2024.
  • Over the past 5 years, Fractyl Health's EBITDA Margin peaked at 16493.06% during Q2 2023, and registered a low of 840333.33% during Q4 2024.